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ABBREVIATIONS  
ASIA, American Spinal Injuries Association 
cCPPopt, continuous optimum cerebral perfusion pressure. Using a sliding 4-hour window that is 
updated every minute, PRx is plotted against cerebral perfusion pressure. cCPPopt is the 
cerebral perfusion pressure at which PRx is minimum, i.e. the cerebral perfusion pressure 
that optimizes brain vascular pressure reactivity. cCPPopt applies to individual patients and 
is updated every minute. 
cSCPPopt, continuous optimum spinal cord perfusion pressure. Using a sliding 4-hour window, 
the SCPP of an individual patient is divided into 5 mmHg bins between 40 – 120 mmHg 
and the mean sPRx for each bin is computed. sPRx is plotted against SCPP and cSCPPopt 
is the SCPP at which sPRx is minimum, i.e. the SCPP that optimizes spinal cord vascular 
pressure reactivity. cSCPPopt applies to an individual patient and is updated every minute. 
CSF, cerebrospinal fluid 
igSCPPopt, individual global optimum spinal cord perfusion pressure. Using the entire SCPP 
signal of an individual patient, SCPP is divided into 5 mmHg bins between 40 – 120 
mmHg and the mean sPRx for each bin is computed. sPRx is plotted against SCPP. 
igSCPPopt is the SCPP at which sPRx is minimum, i.e. the SCPP that optimizes spinal cord 
vascular pressure reactivity. The igSCPPopt value applies to the entire signal of an 
individual patient. 
ISP, intraspinal pressure. Pressure of the swollen spinal cord at the injury site, as it is compressed 
against dura. 
MAP, mean arterial pressure 
MD, microdialysis 
pSCPPopt, pooled optimum spinal cord perfusion pressure. Using the SCPP signals of several 
patients, SCPP is divided into 5 mmHg bins between 40 – 120 mmHg and the mean sPRx 
for each bin is computed. sPRx is plotted against SCPP. pSCPPopt is the SCPP at which 
sPRx is minimum, i.e. the SCPP that optimizes spinal cord vascular pressure reactivity. 
The pSCPPopt value applies to the entire patient group. 
SCPP, spinal cord perfusion pressure. Mean arterial pressure minus intraspinal pressure. 
sPRx, spinal vascular pressure reactivity index. This is the running correlation coefficient 
between ISP and MAP. sPRx ≤ 0 indicates intact pressure reactivity, whereas sPRx > 0 
indicates impaired pressure reactivity  
TSCI, traumatic spinal cord injury  
ABSTRACT 
The optimum spinal cord perfusion pressure (SCPP) after traumatic spinal cord injury (TSCI) is 
unknown. Here, we describe techniques to compute and display the optimum SCPP in real-time. 
We recruited adults within 72 hours of severe TSCI (ASIA grades A–C). A pressure probe and a 
microdialysis catheter were placed on the injured cord. SCPP was computed as mean arterial 
pressure (MAP) minus intraspinal pressure (ISP), spinal pressure reactivity index (sPRx) as the 
running ISP/MAP correlation coefficient and continuous optimum SCPP (cSCPPopt) as the SCPP 
that minimizes sPRx in a moving four-hour window. In 45 patients, we monitored ISP and blood 
pressure. In 14 patients, we also monitored injury site metabolism. cSCPPopt could be computed 
45 % of the time. Mean cSCPPopt varied by up to 60 mmHg between patients. Each patient’s 
cSCPPopt varied with time (standard deviation 10–20 mmHg). Color-coded maps showing the 
sPRx/SCPP curve evolution enhanced visualization of cSCPPopt. Periods when SCPP ≈ cSCPPopt 
were associated with low injury site glucose, high pyruvate and high lactate. Mean SCPP 
deviation from cSCPPopt inversely correlated with neurological outcome at 9–12 months: ASIA 
grade improved in 30 % patients with <5 mmHg deviation, 10 % with 5–15 mmHg deviation and 
no-one with >15 mmHg deviation. We conclude that real-time computation and visualization of 
cSCPPopt after TSCI are feasible. cSCPPopt appears to enhance glucose utilization at the injury 
site and varies widely between and within patients. Our data suggest that targeting cSCPPopt after 
TSCI might improve neurological outcome.   
INTRODUCTION 
About 180,000 people suffer a traumatic spinal cord injury (TSCI) each year 1. The 
consequences are catastrophic; most patients remain dependent or wheelchair-bound. Currently, 
the early management of TSCI patients in the neurointensive care unit is variable: In the U.K. 
there are no clear blood pressure targets 2 whereas the American Association of Neurological 
Surgeons’ guideline of 85 – 95 mmHg mean arterial pressure (MAP) has little supporting 
evidence 3. To aid patient management, we developed techniques for monitoring intraspinal 
pressure (ISP), spinal cord perfusion pressure (SCPP), spinal pressure reactivity (sPRx) 4, 5 and 
metabolism 6 from the injury site. These techniques are safe based on a recent review of 42 
patients 7. In general, the optimum spinal cord perfusion pressure (SCPPopt), defined as the 
perfusion pressure that minimizes sPRx 5, is around 90 mmHg. In our original analysis, SCPPopt 
was computed by pooling data from 18 patients 4, 5. Our initial concept of a pooled SCPPopt 
requires revision for several reasons: First, there is now evidence that SCPPopt varies between 
patients 8 and that the injury site metabolic response is individualistic 9 thus targeting 90 mmHg 
may not benefit everyone. Second, the SCPPopt of each patient may change with time. Third, the 
SCPPopt can only be computed after the monitoring has been completed and is, therefore, not 
clinically useful. Here, we show how to compute a continuous SCPPopt (cSCPPopt) in real-time 
and provide evidence that achieving this cSCPPopt may be beneficial after TSCI. 
 
  
MATERIALS AND METHODS 
Patient recruitment. Approval for the Injured Spinal Cord Pressure Evaluation (ISCoPE) study, 
including the patient information sheet and consent form, was obtained from the St George’s 
Joint Research Office and the National Research Ethics Service London – St Giles Committee 
(No. 10/H0807/23). The study is registered with https://clinicaltrials.gov as NCT02721615. 
Inclusion criteria are: 1. Severe TSCI defined as American Spinal Injuries Association (ASIA) 
grade A, B or C; 2. Age 18 – 70 years; 3. Timing between TSCI and surgery ≤72 hours. 
Exclusion criteria are: 1. Patient unable to consent; 2. Other major injuries or co-morbidities; 3 
Penetrating TSCI. Surgery and early management took place at the neurosurgery and 
neurointensive care units of St. George’s Hospital. Recruitment into the study was discussed 
with all eligible patients and their families on admission and a patient information sheet was 
given. Each patient signed a consent form.  
 
Probe placement. Following bony realignment and posterior fixation, a pressure probe (Codman 
Microsensor Transducer®, Depuy Synthes, Leeds, UK) and a microdialysis (MD) catheter 
(CMA microdialysis AB, Sweden) were tunnelled through skin into the wound cavity. Under the 
operating microscope, the dura was opened one level below the injury. The pressure probe and 
MD catheter were inserted through the durotomy and placed on the spinal cord surface. We 
previously showed that the surface MD catheter samples from the injured spinal cord, not the 
cerebrospinal fluid (CSF) 6. The dural opening was sutured and supplemented with fibrin glue 
(Tisseel®, Baxter, UK). The ISP probe and MD catheter were secured to the skin with silk 
sutures. A wound drain was set at gravity drainage for a week. Patients were given 5,000 units 
dalteparin daily starting on the day after the surgery. Dalteparin was omitted 24 hours before 
removing the probes and wound drain. 
 
Patient assessments. Neurological examinations were done on admission and at two weeks 
postoperatively, i.e. before discharge to the rehabilitation facility. A CT and MRI of the whole 
spine were done on admission. Another CT was done within 48 hours of surgery to check screw 
and probe positions. MRI of the injured spinal cord was done at about two weeks and at 6–12 
months after surgery. 
 
Intraspinal pressure and spinal cord perfusion pressure. The pressure probe was connected 
to a Codman Intracranial Pressure box linked via a ML221 amplifier to a PowerLab running 
LabChart v.7.3.5 (AD Instruments, Oxford, UK). Blood pressure was recorded from a radial 
artery catheter, kept at the same level as the ISP probe, connected to the Philips Intellivue 
MX800 bedside monitoring system (Philips, Guildford, UK) in turn connected to the PowerLab 
system. The ISP and arterial blood pressure signals were sampled at 1 kHz for up to a week. 
LabChart was used to compute SCPP, defined as mean arterial pressure (MAP) minus ISP. 
 
Spinal pressure reactivity. The spinal pressure reactivity index sPRx, a measure of spinal cord 
vascular reactivity, is the running correlation coefficient between ISP and MAP calculated over a 
five-minute period as described 4, 5. If the spinal cord vasculature reacts normally, sPRx ≤ 0. If 
autoregulation is impaired, sPRx > 0.  
 
Microdialysis. MD monitoring was started postoperatively in the neurointensive care unit. 
Central nervous system perfusion fluid (CMA Microdialysis AB, Sweden) was perfused at a rate 
of 0.3 µL/min using the CMA106 infusion pump (CMA Microdialysis AB, Sweden). MD vials 
were changed hourly, stored at 4 °C, and batched analysed up to 24 hours later using ISCUS Flex 
(CMA Microdialysis AB, Sweden). The first two samples from each patient were discarded to 
allow priming of the MD catheter and stabilization of the metabolite concentrations. All samples 
were analyzed for glucose, lactate, pyruvate, glycerol and glutamate. 100-fold changes in 
metabolite concentration, compared with the preceding hour, were excluded from analysis. For 
details see our earlier papers 6, 10. 
 
Optimum spinal cord perfusion pressure. We used the software ICM+ 
(www.neurosurg.cam.ac.uk/icmplus). SCPP was divided into 5 mmHg bins between 40 – 120 
mmHg and the mean sPRx for each bin was computed. To obtain the pooled SCPPopt (pSCPPopt) 
we used the entire signal of each patient. We averaged the sPRx for all patients in each SCPP bin 
and plotted these values versus SCPP. pSCPPopt is the minimum of this curve. The same method 
was used to plot sPRx (averaged for all patients) versus ISP. To obtain the individual global 
spinal cord perfusion pressure (igSCPPopt), we used the entire signal of each patient and plotted 
sPRx versus SCPP curve for each patient (rather than averaging over all patients). The igSCPPopt 
is the minimum of each curve. The same method was used to obtain the individual continuous 
optimum spinal cord perfusion pressure (cSCPPopt), but by using a four-hour window (unless 
otherwise stated) rather than the entire signal, moving forward each minute. 
 
Enhanced visualization. sPRx versus SCPP curves were produced each minute, using a sliding 
four-hour window. The horizontal axis is time and the vertical axis is SCPP. At each time point, 
sPRx values are color-coded green (intact reactivity), yellow (borderline reactivity) or red 
(impaired reactivity). Time points, for which no cSCPPopt could be determined, are represented 
by vertical bands filled with monotonic green. A non-causal, exponentially weighted moving 
average filter was the applied to the image along the time axis. This filter has a smoothing effect 
in time and fills in some of the gaps with appropriately weighted average of the preceding and 
following data values. The measured cSCPPopt values were smoothed with the same filter and 
added to the image. Details are given elsewhere 11. The images shown here were generated in 
ICM+ with the current implementation of the MATLAB tool 12.  
 
Statistical analysis. Two-tailed t-test was used to compare metabolite level within 5 mmHg 
versus more than 5 mmHg from the cSCPPopt with significance at P < 0.01** and 0.005. We 
used the Spearman coefficient to quantify the correlation between neurological outcome versus 
deviation from cSCPPopt or MAP guideline. 
 
  
RESULTS 
Demographics. Table 1 summarizes details of the 45 patients. Most are young, with 84 % <60 
years old. Males outnumber females by 3.5:1. Cervical TSCIs are more common than thoracic at 
56 vs. 44 %. Most had neurologically complete TSCI on admission; two thirds were ASIA grade 
A. Overall, 13 % (6/45) patients improved by one grade and 16 % (7/45) by at least two grades at 
9 – 12 months. Of those who were grade A 17 % improved versus 44 % of grade B and 67 % of 
grade C. 
 
Pooled SCPPopt. Using data from all 45 patients, we plotted sPRx versus ISP and sPRx versus 
SCPP. Figure 1A shows that as ISP increases, sPRx increases. This suggests that higher ISP 
correlates with more marked loss of injury site autoregulation. Figure 1B shows a U-shaped 
relationship between sPRx and SCPP, which suggests that the optimum SCPP is around 80 – 90 
mmHg. As SCPP falls below 80 mmHg or rises above 90 mmHg, injury site autoregulation 
progressively worsens. Since the optimum SCPP of 80 – 90 mmHg was computed by pooling 
data from all patients, we term this pooled SCPPopt (pSCPPopt). A major drawback of pSCPPopt is 
that it does not provide information about the variability of SCPPopt between patients. 
 
Individual global SCPPopt. To test the hypothesis that SCPPopt varies between patients, we 
computed SCPPopt for individual patients by plotting the sPRx versus SCPP for each individual 
patient. We termed this the individual global (igSCPPopt) because it only applies to an individual 
patient and the entire monitoring period is used. Figure 1C shows sPRx versus SCPP curve for 
three patients; two had a U-shaped relationship with approximately 20 mmHg difference in their 
igSCPPopt, whereas in one there was no correlation between sPRx and SCPP. igSCPPopt values 
ranged from 50 – 60 mmHg in some patients up to 100 – 110 mmHg in others (Figure 1D). In 13 
% (6/45) patients, igSCPPopt could not be computed because the relation between sPRx versus 
SCPP is not U-shaped. Unlike pSCPPopt, which is averaged over many patients, igSCPPopt 
provides individual patient information. Because igSCPPopt requires the entire ISP and MAP 
signals, igSCPPopt does not indicate how a patient’s SCPPopt changes with time and can only be 
computed after the monitoring has ended. Thus, igSCPPopt cannot be used to guide patient 
management in real time in the neurointensive care unit. 
 
Individual continuous SCPPopt. To overcome the problems with igSCPPopt, we computed a 
running SCPPopt for each patient, which we term the individual continuous SCPPopt, abbreviated 
as cSCPPopt, by analogy to the continuous optimum cerebral perfusion pressure (cCPPopt) for 
brain injury 11, 13. cSCPPopt was calculated using a four-hour window, updated every minute. Fig. 
2 shows sPRx versus SCPP plots, obtained using four-hour windows. Some plots (plot a) were 
U-shaped thus allowing cSCPPopt to be computed. In other cases, cSCPPopt could not be 
calculated because the injured cord was underperfused (descending curve, plot b) or 
overperfused (ascending curve, plot c) or there was no correlation between sPRx and SCPP (plot 
d). We then varied the time window from 2 – 10 hours to compute the cSCPPopt. For each time 
window the SCPPopt is calculated, the window is moved forward 60 seconds and the 
SCPPopt result is updated. The process continues for the entire SCPP signal. Therefore, when 
process is finished, there is a SCPPopt vector every 60 seconds. Each vector has four components 
(a, b, c, d) and can be (1, 0, 0, 0), (0, 1, 0, 0), (0, 0, 1, 0) or (0, 0, 0, 1) as follows: a - optimum 
value found, b - hypoperfused, c - hyperperfused, d - no relation between sPRx and SCPP. We 
then computed the frequencies with which a, b, c, d occur in the entire SCPP signal. The process 
was repeated for each patient. Fig. 2B shows that time windows greater or equal to four hours 
maximize the chance of obtaining the cSCPPopt. With a four-hour window, cSCPPopt could be 
computed 45 % of the time. Fig. 3 shows many signals (ISP, MAP, SCPP, sPRx, and cSCPPopt) 
simultaneously displayed for a single patient. SCPP – cSCPPopt is also displayed to allow doctors 
to see in real-time how their treatment deviates from the optimum.  
 
Histograms of continuous SCPPopt. We plotted each patient’s cSCPPopt histogram (Fig. 4A). 
Distributions varied widely; some were unimodal-symmetrical with a predominant cSCPPopt 
peak (patient i) or a wide range of cSCPPopt values (patient ii) or bi-modal (patient iii). Left- and 
right-skewed unimodal distributions were also found (not shown). Fig. 4B shows the standard 
deviations of these distributions; in most patients, the standard deviation was high at 10 – 15 
mmHg and in some as high as 15 – 20 mmHg. The high variability in cSCPPopt suggests that a 
patient’s SCPPopt is dynamic and, therefore, targeting the same SCPP is inadequate. Fig. 4C 
shows significant positive correlation between igSCPPopt and mean cSCPPopt. 
 
Neurological outcome. We hypothesized that larger deviation of SCPP from cSCPPopt correlates 
with worse neurological outcome at 9 – 12 months. The data show that as the difference between 
SCPP and the cSCPPopt (averaged over each patient’s entire monitoring period) decreases, the 
chance of ASIA grade improvement increases (Fig. 5A) and the chance of having a complete 
neurological deficit at follow-up (ASIA A) decreases (Fig. 5B). There are only two patients with 
positive mean deviation of SCPP from cSCPPopt; thus, we do not know if hyperperfusion 
correlates with worse neurological outcome. There was no correlation between the American 
Association of Neurological Surgeons’ guideline of 85 – 95 mmHg MAP and the chance of 
ASIA grade improvement (Fig. 5C) or the chance of having complete deficit (Fig. 5D) at 9 – 12 
months.  
 
Enhanced visualization. Displaying cSCPPopt as a line (Fig. 3) is clinically helpful, but has 
drawbacks. First, it fails to show the range of cSCPPopt at any one time that are associated with 
intact autoregulation, i.e. sPRx ≤ 0; a cSCPPopt line simplistically implies that cSCPPopt at any 
one time is a single value rather than a range. Second, the cSCPPopt line has gaps whenever the 
optimum cannot be calculated. We, therefore, used an enhanced visualization technique, recently 
developed to overcome these issues when monitoring in severe traumatic brain injury 11, 12. Fig. 6 
shows two monitoring periods from the same TSCI patient. The top trace shows a wide range (60 
– 90 mmHg) of cSCPPopt. Initially, the actual SCPP was within this range, but between 00:30 
and 01:45 hours the injured cord was hypoperfused. After two days (bottom trace) the range of 
cSCPPopt narrowed substantially. Between 13:00 and 14:00 hours, the cSCPPopt range was 
narrow at around 78 mmHg, between 14:00 and 16:00 hours it was 65 – 85 mmHg and, after 
18:30, it narrowed again at around 85 mmHg. The enhanced visualization technique not only 
displays the range of cSCPPopt values at any one time, but also fills some of the gaps in the 
signal. 
 
Injury site metabolism. After TSCI, injury site metabolism can be monitored using surface MD 
6. We hypothesized that small deviation of SCPP from cSCPPopt correlates with less injury site 
metabolic derangement. To test this, we quantified the hourly injury site metabolic state in 14 
spinal cord injury patients. Figure 7 shows that hourly SCPP close to cSCPPopt is associated with 
low injury site glucose, high lactate and high pyruvate. As SCPP deviates from cSCPPopt by 
more than 5 mmHg, injury site glucose rises whereas lactate and pyruvate fall. Therefore, 
cSCPPopt does not minimize injury site metabolic derangement, but appears to maximize glucose 
utilization at the injury site. There was no correlation between deviation from cSCPPopt and 
glutamate, glycerol or lactate-to-pyruvate ratio (not shown). cSCPPopt was not associated with a 
unique metabolic profile (Supplement). 
 
  
DISCUSSION 
In this study, we introduced the novel concept of cSCPPopt, which is a range rather than an 
individual number. To guide the management of TSCI patients, we showed how cSCPPopt could 
be displayed in real-time using an enhanced visualization method.  
 Our data show that cSCPPopt varies widely between and within patients. Various reasons 
may explain such wide inter-patient variability: patients with more extensive microvascular 
damage, pre-existing hypertension or greater leukocyte infiltration at the injury site will likely 
require higher SCPP. The large intra-patient variability in cSCPPopt may be due to the dynamic 
nature of the pathological processes at the injury site e.g. changes in the numbers of infiltrating 
leukocytes 14 and reactive glia 15 as well as changes in injury site edema 16-18 and fever 19. Most 
cSCPPopt distributions are unimodal, but some are bimodal. A bimodal distribution may arise by 
sudden events that reset the cSCPPopt, e.g. spinal cord hemorrhage. Further studies are required 
to clarify the significance of the different cSCPPopt distributions. Based on our data, we suggest 
that targeting the same SCPP continuously in all patients is inadequate. 
 cSCPPopt could only be computed 45 % of the time. It would be clinically useful for 
cSCPPopt to be computable more often. One way to achieve this may be by using a Dynamic 
Adaptive Target of Cerebral Autoregulation algorithm, to combine different sPRx values and 
time windows in a weighted manner to issue a cSCPPopt recommendation. When applied to 
cerebral perfusion pressure obtained from TBI patients, such an algorithm produced a CPPopt 
recommendation 97% of the entire monitoring period 20, 21. 
 Is actively targeting cSCPPopt safe? Our audit of 42 patients concluded that insertion of 
the pressure probe and ISP monitoring for up to a week are safe 7. However, actively increasing 
SCPP requires vasopressors, which may produce complications such as cardiac dysrhythmias, 
especially in older patients 22, 23. We previously showed that, after TSCI, the spinal cord swells 
and is compressed by the dura 24. Thus, one way to reduce vasopressor requirements is expansion 
duroplasty, a simple and safe surgical procedure that lowers ISP and sPRx as well as increasing 
SCPP 8. Based on our experience thus far, SCPP monitoring is safe and helpful to guide 
management of TSCI patients 25. 
 Is targeting cSCPPopt beneficial? Our MD data suggest that cSCPPopt maximizes glucose 
utilization by the injured cells. The Kohonen self-organizing maps 9 show that each patient’s 
injury site metabolic response is unique. Therefore, each patient’s optimal injury site metabolic 
profile must also be unique, which explains why cSCPPopt is not associated with a single 
metabolic signature (Supplement). How about neurological outcome? We found that larger 
deviation from cSCPPopt (hypoperfusion) is associated with worse neurological outcome at 9 – 
12 months, though the effect of hyperperfusion on neurological outcome could not be 
determined. Aries et al. 13 showed that increased deviation from cCPPopt is associated with worse 
neurological outcome after brain injury. These observations suggest that targeting the continuous 
optimum perfusion pressure may be beneficial after central nervous system injury.  
Are there ways of managing spinal cord perfusion without targeting cSCPPopt? One may 
follow the 85 – 95 mmHg MAP guideline 3 or drain CSF with a lumbar catheter 26. MAP-
oriented management may be inadequate, evident by the lack of a strong correlation between 
achieving the guideline and neurological outcome as shown in Fig. 6 and by others 23, 27, 28. A 
major drawback of the MAP guideline is that it does not consider ISP; thus, the same MAP may 
hypoperfuse the injury site in one patient and hyperperfuse it in another. Also, the MAP 
guideline does not consider inter- and intra- patient variability in SCPPopt. Draining lumbar CSF 
is also likely inadequate because, at the injury site, the cord is not surrounded by CSF, but is 
compressed against dura 5, 8, 24, 29, 30. Thus, CSF drainage is unlikely to reduce injury site ISP. 
Ultimately, a randomized controlled trial is required to definitively determine whether 
interventions to achieve cSCPPopt improve neurological outcome after TSCI. 
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TABLES 
Table 1. Patients’ demographic characteristics. 
 
CHARACTERISTIC NUMBER % 
AGE   
≤20 3 6.7 
21 – 30  9 20.0 
31 – 40  11 24.4 
41 – 50  8 17.8 
51 – 60  7 15.6 
61 – 70  7 15.6 
   
SEX   
Male : female 35 : 10 77.8 : 22.2 
   
LEVEL OF INJURY   
Cervical 25 55.6 
Upper thoracic (T1 – T6) 10 22.2 
Lower thoracic (T7 – T10) 3 6.7 
Conus medullaris (T11 – L2) 7 15.5 
   
ADMISSION AIS GRADE   
A 30 66.7 
B 9 20.0 
C 6 13.3 
   
AIS GRADE IMPROVEMENT   
From A  1 2 6.7 
 >1 3 10.0 
From B  1 2 22.2 
 >1 2 22.2 
From C  1 2 33.3 
 >1 2 33.3 
 
 
FIGURE LEGENDS 
Fig. 1. Concepts of pSCPPopt and igSCPPopt. A. sPRx versus ISP and B. sPRx vs. SCPP using 
pooled data from 45 patients. Dotted line shows pSCPPopt. C. sPRx vs. SCPP for three patients 
(a, b, c). Dotted line shows igSCPPopt. D. igSCPPopt values for 45 patients. Nil means igSCPPopt 
not computable. Mean ± standard error. 
 
Fig. 2. Concept of cSCPPopt. A. Four sets (a, b, c, d) of corresponding ISP, MAP, SCPP and 
sPRx signals. cSCPPopt can be obtained in ‘a’, but not in ‘b’ (hypoperfused), ‘c’ (hyperperfused) 
or ‘d’ (no relation between sPRx and SCPP). B. % time versus ‘a’, ‘b’, ‘c’ and ‘d’ for time 
windows between 2 – 10 hours. Mean ± standard error. 
 
Fig. 3. Simultaneous display of multiple signals. Simultaneously displayed ISP, MAP, SCPP 
and sPRx, cSCPPopt and SCPP – cSCPPopt signals from one patient. 
 
Fig. 4. Distribution of cSCPPopt values. A. cSCPPopt distributions in three patients: i – 
unimodal leptokurtic, ii – unimodal pachykurtic, iii – bimodal. B. Standard deviations of the 45 
cSCPPopt distributions. C. igSCPPopt versus mean cSCPPopt for 45 patients and best-fit straight 
line (R2 = 0.56). 
 
Fig. 5. Deviation of SCPP from cSCPPopt versus neurological outcome. A. % patients who 
improved by at least one ASIA grade versus mean SCPP – cSCPPopt (R2 = 0.95). B. % patients 
with complete (ASIA A) neurological deficit at follow-up versus mean SCPP – cSCPPopt (R2 = 
1.00). C. % patients who improved by at least one ASIA grade vs. mean deviation from the 85 – 
95 mmHg MAP Guideline (R2 = 0.38). D. % patients with complete (ASIA A) neurological 
deficit at follow-up versus mean deviation from MAP Guideline (R2 = 0.67).  
 
Fig. 6. Enhanced visualization of cSCPPopt. Plots of SCPP versus time for two periods (4 Jan, 
6 Jan). sPRx zones: Red (loss of autoregulation), Green (preserved autoregulation) and Yellow 
(transition from preserved to impaired autoregulation) as per color scale. Line shows actual 
SCPP. 
 
Fig. 7. Deviation of SCPP from cSCPPopt versus injury site metabolism. Glucose, lactate and 
pyruvate concentration versus mean hourly SCPP – cSCPPopt. Mean ± standard error. P < 
0.01**, < 0.005♯ for metabolite level at -5 – 5 mmHg compared with all others together. 
 
 







SUPPLEMENTARY,DATA,
,
Kohonen&self*organizing&maps.&We,define,a,vector,as,a,set,of,five,metabolite,
measurements,at,a,time,point.,We,first,removed,outliers,and,interpolated,vectors,with,
missing,components,as,we,described,1.,After,filtering,and,interpolation,,the,MD,dataset,
comprised,1,611,fiveGdimensional,vectors.,The,five,metabolites,were,then,normalized,to,a,
mean,of,zero,and,unit,standard,deviation.&Subsequent,analysis,was,done,using,the,selfG
organizing,map,(SOM),toolbox,for,Matlab,v.2.0beta,at,www.cis.hut.fi/somtoolbox/,2.,The,
grid,length,and,width,were,computed,from,the,ratio,between,the,eigenvalues,of,the,
training,data.,The,grid,was,initialized,using,random,weight,vectors,as,we,described,1.,The,
SOM,algorithm,uses,competitive,learning,to,project,the,fiveGdimensional,vectors,onto,a,
twoGdimensional,map,where,similar,vectors,are,cluster,close,to,each,other.,The,algorithm,
preserves,topological,relationships,between,the,fiveGdimensional,vectors,as,they,are,
mapped,onto,the,twoGdimensional,grid,thus,facilitating,visualization,of,clinically,important,,
nonGlinear,relationships,between,the,vectors.,We,colored,the,Kohonen,grid,by,metabolite,
level,,patient,number,and,mean,hourly,deviation,from,the,cSCPPopt.,For,details,see,our,
earlier,paper,1.,
We,determined,whether,cSCPPopt,is,associated,with,a,specific,injury,site,metabolic,
signature.,Supplementary,Fig.,1A,shows,Kohonen,metabolite,SOMs.,The,upper,part,of,the,
SOM,indicates,high,glucose,,low,lactate,,pyruvate,,glutamate,and,glycerol,and,thus,
represents,nearGnormal,metabolism.,The,bottom,left,of,the,SOM,indicates,low,glucose,,high,
lactate,and,high,pyruvate,and,thus,represents,hypermetabolism.,The,bottom,right,part,of,
the,SOM,indicates,low,glucose,,high,lactate,,medium,pyruvate,as,well,as,high,glutamate,and,
glycerol,and,thus,represents,ischemia.,Patients,occupy,different,regions,of,the,metabolic,
map,,which,suggests,that,they,have,individualistic,injury,site,metabolic,responses,to,TSCI,
(Supplementary,Fig.,1B,,left).,Supplementary,figure,1B,(right),shows,that,the,yellow,
hexagons,are,scattered,throughout,the,map,,i.e.,having,SCPP,within,5,mmHg,of,cSCPPopt,is,
not,associated,with,a,unique,metabolic,signature.,This,finding,suggests,that,the,optimum,
injury,site,metabolic,response,differs,between,patients.,
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Suppl.&Fig.&1.&Deviation&of&SCPP&from&cSCPPopt&versus&injury&site&metabolism.&A.,Kohonen,
SOMs,of,injury,site,glucose,,lactate,,pyruvate,,glutamate,and,glycerol.,Heat,maps,with,the,
average,value,in,each,hexagon,colour,coded.,B.,(left),Kohonen,SOM,coloured,by,patient,(P1,
–,P14).,Each,hexagon,is,coloured,according,to,the,patient,with,the,most,vectors,in,that,
hexagon.,(right),Kohonen,SOM,colored,according,to,deviation,from,cSCPPopt.,Each,hexagon,
is,color,coded,according,to,its,mean,SCPP,–,SCPPopt,value.,
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